Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abnormalities, Multiple | 9 | 2021 | 109 | 0.570 |
Why?
|
| Intellectual Disability | 5 | 2021 | 114 | 0.560 |
Why?
|
| X Chromosome | 5 | 1997 | 28 | 0.430 |
Why?
|
| Mosaicism | 4 | 2004 | 21 | 0.380 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 119 | 0.340 |
Why?
|
| Trisomy | 4 | 2004 | 47 | 0.280 |
Why?
|
| Mass Screening | 1 | 2010 | 838 | 0.240 |
Why?
|
| Retinal Dystrophies | 1 | 2022 | 4 | 0.210 |
Why?
|
| Retinitis Pigmentosa | 1 | 2022 | 17 | 0.210 |
Why?
|
| Genetic Linkage | 3 | 1997 | 90 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2021 | 3 | 0.190 |
Why?
|
| Osteolysis, Essential | 2 | 1993 | 6 | 0.190 |
Why?
|
| Ectodermal Dysplasia | 1 | 2021 | 8 | 0.190 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 42 | 0.190 |
Why?
|
| Diagnostic Errors | 2 | 1998 | 100 | 0.180 |
Why?
|
| Adrenoleukodystrophy | 1 | 2000 | 45 | 0.180 |
Why?
|
| Child | 13 | 2010 | 6401 | 0.180 |
Why?
|
| Skin Neoplasms | 3 | 1993 | 375 | 0.170 |
Why?
|
| Lovastatin | 1 | 2000 | 78 | 0.170 |
Why?
|
| Translocation, Genetic | 3 | 1996 | 74 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 1998 | 54 | 0.160 |
Why?
|
| Infant | 8 | 2021 | 2891 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2000 | 212 | 0.150 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1997 | 6 | 0.150 |
Why?
|
| Prenatal Diagnosis | 1 | 1998 | 73 | 0.150 |
Why?
|
| Child, Preschool | 8 | 2010 | 3187 | 0.130 |
Why?
|
| Ring Chromosomes | 1 | 1995 | 1 | 0.130 |
Why?
|
| Turner Syndrome | 1 | 1995 | 10 | 0.130 |
Why?
|
| Porphyria, Erythropoietic | 1 | 1994 | 2 | 0.120 |
Why?
|
| Female | 24 | 2021 | 38021 | 0.120 |
Why?
|
| Genitalia, Male | 1 | 1994 | 14 | 0.120 |
Why?
|
| Hemiplegia | 1 | 1994 | 29 | 0.120 |
Why?
|
| Infant, Newborn | 11 | 2004 | 2455 | 0.120 |
Why?
|
| Brain Diseases | 1 | 1994 | 78 | 0.120 |
Why?
|
| Syndrome | 6 | 2000 | 255 | 0.120 |
Why?
|
| Retinal Degeneration | 1 | 1994 | 75 | 0.110 |
Why?
|
| Fibroma | 1 | 1993 | 20 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1992 | 3 | 0.110 |
Why?
|
| Humans | 29 | 2022 | 68549 | 0.110 |
Why?
|
| Centromere | 1 | 1992 | 15 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1992 | 17 | 0.110 |
Why?
|
| Bleomycin | 2 | 1992 | 67 | 0.110 |
Why?
|
| Proteus Syndrome | 1 | 1992 | 1 | 0.110 |
Why?
|
| Lipomatosis | 1 | 1992 | 4 | 0.110 |
Why?
|
| Male | 20 | 2010 | 37283 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 1992 | 100 | 0.100 |
Why?
|
| Fragile X Syndrome | 1 | 2010 | 17 | 0.090 |
Why?
|
| Lymphocytes | 2 | 1992 | 228 | 0.080 |
Why?
|
| Keratosis | 1 | 1989 | 17 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 1989 | 35 | 0.080 |
Why?
|
| Osteolysis | 1 | 1988 | 15 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 1994 | 694 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 1996 | 144 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 1989 | 397 | 0.070 |
Why?
|
| Obesity | 1 | 1994 | 1074 | 0.070 |
Why?
|
| Diagnosis, Differential | 5 | 1995 | 1140 | 0.070 |
Why?
|
| Adolescent | 7 | 2010 | 8904 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 2222 | 0.060 |
Why?
|
| Extraembryonic Membranes | 1 | 2004 | 10 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 28 | 0.060 |
Why?
|
| Wilms Tumor | 1 | 2004 | 47 | 0.060 |
Why?
|
| Fibroblasts | 2 | 1990 | 902 | 0.060 |
Why?
|
| Dosage Compensation, Genetic | 2 | 1995 | 2 | 0.060 |
Why?
|
| DNA Probes | 2 | 1995 | 57 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 206 | 0.060 |
Why?
|
| Calcinosis | 1 | 2004 | 241 | 0.060 |
Why?
|
| Usher Syndromes | 1 | 2022 | 5 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2022 | 24 | 0.050 |
Why?
|
| Adult | 9 | 2004 | 21379 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 1994 | 86 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2022 | 81 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 132 | 0.050 |
Why?
|
| Pedigree | 3 | 1997 | 159 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 108 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 120 | 0.050 |
Why?
|
| Chromatids | 2 | 1992 | 8 | 0.050 |
Why?
|
| Karyotyping | 3 | 1996 | 74 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 3256 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 230 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2000 | 45 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2000 | 46 | 0.050 |
Why?
|
| Platelet Count | 1 | 2000 | 100 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2000 | 87 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 370 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2000 | 222 | 0.040 |
Why?
|
| South Carolina | 2 | 2022 | 2752 | 0.040 |
Why?
|
| DNA | 1 | 2000 | 597 | 0.040 |
Why?
|
| Neurobehavioral Manifestations | 1 | 1997 | 1 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1997 | 26 | 0.040 |
Why?
|
| Williams Syndrome | 1 | 1997 | 13 | 0.040 |
Why?
|
| Risk Factors | 2 | 2000 | 5720 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1997 | 40 | 0.040 |
Why?
|
| Child Behavior | 1 | 1997 | 56 | 0.040 |
Why?
|
| Hydrocephalus | 2 | 1995 | 40 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 188 | 0.040 |
Why?
|
| Growth Disorders | 1 | 1996 | 21 | 0.040 |
Why?
|
| Dwarfism | 1 | 1996 | 5 | 0.040 |
Why?
|
| Face | 2 | 1996 | 46 | 0.040 |
Why?
|
| Craniofacial Abnormalities | 1 | 1996 | 18 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 23 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 201 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1995 | 41 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 1997 | 264 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1994 | 25 | 0.030 |
Why?
|
| India | 1 | 1994 | 41 | 0.030 |
Why?
|
| Hearing Disorders | 1 | 1994 | 23 | 0.030 |
Why?
|
| Registries | 1 | 1997 | 730 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1994 | 107 | 0.030 |
Why?
|
| Eye Abnormalities | 1 | 1994 | 15 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1994 | 17 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 1997 | 447 | 0.030 |
Why?
|
| Pigmentation Disorders | 2 | 1992 | 11 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1992 | 4 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 1992 | 17 | 0.030 |
Why?
|
| Neck | 1 | 1993 | 62 | 0.030 |
Why?
|
| Pregnancy | 4 | 2004 | 2334 | 0.030 |
Why?
|
| Nails | 1 | 1992 | 15 | 0.030 |
Why?
|
| Leukoplakia, Oral | 1 | 1992 | 12 | 0.030 |
Why?
|
| G2 Phase | 1 | 1992 | 26 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 1992 | 25 | 0.030 |
Why?
|
| Seizures | 1 | 1994 | 279 | 0.030 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1991 | 4 | 0.020 |
Why?
|
| Biopsy | 1 | 1993 | 539 | 0.020 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 1990 | 6 | 0.020 |
Why?
|
| Chromosome Banding | 2 | 2004 | 24 | 0.020 |
Why?
|
| Fatal Outcome | 2 | 2004 | 164 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7268 | 0.020 |
Why?
|
| Skin | 1 | 1993 | 451 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1995 | 2673 | 0.020 |
Why?
|
| Chromosomes | 1 | 1989 | 17 | 0.020 |
Why?
|
| Keratinocytes | 1 | 1989 | 68 | 0.020 |
Why?
|
| Cell Line | 2 | 1990 | 1752 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2000 | 7028 | 0.020 |
Why?
|
| DNA Damage | 1 | 1989 | 190 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 1992 | 596 | 0.020 |
Why?
|
| Radiography | 1 | 1988 | 572 | 0.020 |
Why?
|
| Aged | 1 | 2000 | 14842 | 0.010 |
Why?
|
| Brain | 1 | 1994 | 2176 | 0.010 |
Why?
|
| Muscles | 2 | 1995 | 158 | 0.010 |
Why?
|
| Middle Aged | 1 | 2000 | 21119 | 0.010 |
Why?
|
| Stanford-Binet Test | 1 | 1997 | 2 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 1997 | 27 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1997 | 38 | 0.010 |
Why?
|
| Motor Skills | 1 | 1997 | 88 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1996 | 12 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1996 | 51 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1996 | 12 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1996 | 31 | 0.010 |
Why?
|
| Thorax | 1 | 1996 | 49 | 0.010 |
Why?
|
| Haplotypes | 1 | 1996 | 174 | 0.010 |
Why?
|
| Pelvis | 1 | 1996 | 38 | 0.010 |
Why?
|
| Social Behavior | 1 | 1997 | 164 | 0.010 |
Why?
|
| Autopsy | 1 | 1996 | 56 | 0.010 |
Why?
|
| Spine | 1 | 1996 | 46 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 110 | 0.010 |
Why?
|
| Muscle Hypotonia | 1 | 1995 | 19 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 319 | 0.010 |
Why?
|
| Breast | 1 | 1996 | 137 | 0.010 |
Why?
|
| Head | 1 | 1995 | 59 | 0.010 |
Why?
|
| Leg | 1 | 1996 | 191 | 0.010 |
Why?
|
| Meiosis | 1 | 1994 | 5 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1994 | 18 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1994 | 18 | 0.010 |
Why?
|
| Birth Weight | 1 | 1995 | 186 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1994 | 31 | 0.010 |
Why?
|
| Telomere | 1 | 1994 | 59 | 0.010 |
Why?
|
| Heterozygote | 1 | 1994 | 174 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1994 | 18 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1994 | 64 | 0.010 |
Why?
|
| Mothers | 1 | 1994 | 172 | 0.010 |
Why?
|
| Cerebellum | 1 | 1994 | 103 | 0.010 |
Why?
|
| Phenotype | 1 | 1995 | 946 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1994 | 453 | 0.010 |
Why?
|
| Rhabdomyoma | 1 | 1990 | 7 | 0.010 |
Why?
|
| Facial Neoplasms | 1 | 1990 | 10 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 415 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1992 | 122 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1991 | 107 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 1990 | 7 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 1990 | 10 | 0.010 |
Why?
|
| Metaphase | 1 | 1990 | 12 | 0.010 |
Why?
|
| Interphase | 1 | 1990 | 19 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1991 | 220 | 0.010 |
Why?
|
| X-Rays | 1 | 1990 | 56 | 0.010 |
Why?
|
| Kidney | 1 | 1991 | 945 | 0.000 |
Why?
|